Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estrogen vaginal cream, specifically in the forms of Premarin (conjugated estrogens) or Estrace (estradiol), is a topical hormonal therapy used to treat symptoms of vulvovaginal atrophy and atrophic vaginitis in postmenopausal women. In a Phase 4 clinical trial (NCT03943823) conducted by The University of Texas Health Science Center, Houston, it is being evaluated for its efficacy in reducing vaginal pH, vaginal discharge, and the incidence of bacterial vaginosis in postmenopausal women who use ring with support pessaries. The treatment works by stimulating the maturation of the vaginal epithelium and increasing glycogen levels, which facilitates the growth of Lactobacillus species and the maintenance of an acidic vaginal environment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Estrogen vaginal cream.